Cargando…

Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types

Detalles Bibliográficos
Autores principales:	Azorin, Paula, Bonin, Florian, Tariq, Zakia, Petitalot, Ambre, Coussy, Florence, Marangoni, Elisabetta, Becette, Veronique, Denoux, Yves, Vincent‐Salomon, Anne, Le Tourneau, Christophe, Larbi Cherif, Linda, Klijanienko, Jerzy, Kamal, Maud, Bièche, Ivan, Lidereau, Rosette, Driouch, Keltouma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029018/ https://www.ncbi.nlm.nih.gov/pubmed/35452191 http://dx.doi.org/10.1002/ctm2.813

Ejemplares similares

Kindlin‐1 drives early steps of breast cancer metastasis
por: Bonin, Florian, et al.
Publicado: (2022)

Distinct expression profiles and functions of Kindlins in breast cancer
por: Azorin, Paula, et al.
Publicado: (2018)

VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX
por: Bonin, Florian, et al.
Publicado: (2018)

Molecular Functions of WWOX Potentially Involved in Cancer Development
por: Taouis, Karim, et al.
Publicado: (2021)

WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer
por: Taouis, Karim, et al.
Publicado: (2023)

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
por: Cizkova, Magdalena, et al.
Publicado: (2012)

The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis
por: Lallemand, François, et al.
Publicado: (2020)

Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer
por: Basse, Clémence, et al.
Publicado: (2023)

Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy
por: Bièche, Ivan, et al.
Publicado: (2011)

Involvement of the FOXO6 transcriptional factor in breast carcinogenesis
por: Lallemand, François, et al.
Publicado: (2017)

Update on inflammatory breast cancer
por: Lerebours, Florence, et al.
Publicado: (2005)

KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
por: Rouleau, E, et al.
Publicado: (2008)

Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas
por: Sablin, Marie-Paule, et al.
Publicado: (2016)

Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study
por: Callens, Céline, et al.
Publicado: (2021)

Kindlin-2 interacts with β-catenin and YB-1 to enhance EGFR transcription during glioma progression
por: Ou, Yunwei, et al.
Publicado: (2016)

Identification of a three-gene expression signature of poor-prognosis breast carcinoma
por: Bièche, Ivan, et al.
Publicado: (2004)

Overexpression of the stathmin gene in a subset of human breast cancer.
por: Bièche, I., et al.
Publicado: (1998)

Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma
por: Bièche, Ivan, et al.
Publicado: (2004)

Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas
por: Bièche, I, et al.
Publicado: (2003)

Molecular analyses of human breast cancer metastasis: genetic markers of progression
por: Driouch, K, et al.
Publicado: (2000)

Of Kindlins and Cancer
por: Plow, Edward F., et al.
Publicado: (2016)

De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
por: Morel, Adeline, et al.
Publicado: (2019)

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
por: Tury, Sandrine, et al.
Publicado: (2016)

Opposite Role of Kindlin-1 and Kindlin-2 in Lung Cancers
por: Zhan, Jun, et al.
Publicado: (2012)

MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
por: Cizeron-Clairac, Geraldine, et al.
Publicado: (2015)

GIV•Kindlin Interaction Is Required for Kindlin-Mediated Integrin Recognition and Activation
por: Rohena, Cristina, et al.
Publicado: (2020)

Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18–18 and EGFR amplification: A case report
por: Wang, Pascal, et al.
Publicado: (2022)

NF-kappa B genes have a major role in Inflammatory Breast Cancer
por: Lerebours, Florence, et al.
Publicado: (2008)

Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets
por: Saada-Bouzid, Esma, et al.
Publicado: (2019)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

Gene Expression Profiling Reveals New Aspects of PIK3CA Mutation in ERalpha-Positive Breast Cancer: Major Implication of the Wnt Signaling Pathway
por: Cizkova, Magdalena, et al.
Publicado: (2010)

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
por: Leblanc, Olivia, et al.
Publicado: (2020)

Phylogenetic Analysis of Kindlins Suggests Subfunctionalization of an Ancestral Unduplicated Kindlin into Three Paralogs in Vertebrates
por: Khan, Ammad Aslam, et al.
Publicado: (2011)

HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers
por: El‐Botty, Rania, et al.
Publicado: (2023)

Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
por: El-Botty, Rania, et al.
Publicado: (2023)

Kindlin-1 Regulates Keratinocyte Electrotaxis
por: Zhang, Gaofeng, et al.
Publicado: (2016)

Phosphorylation of Kindlins and the Control of Integrin Function
por: Bialkowska, Katarzyna, et al.
Publicado: (2021)

Kindlins as modulators of breast cancer progression
por: Plow, Edward F., et al.
Publicado: (2021)

Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR(WT), EGFR(T790M), and EGFR(L858R))
por: Abo Al-Hamd, Mahmoud G., et al.
Publicado: (2023)

Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR
por: Li, X, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fulqttbcc9f086dfokbmpsqr4s